The High Proportion of Discordant <i>EGFR</i> Mutations among Multiple Lung Tumors

The High Proportion of Discordant <i>EGFR</i> Mutations among Multiple Lung Tumors

The prevalence of multiple lung cancers has been increasing recently. Molecular analysis of epidermal growth factor receptor (<i>EGFR</i>) mutations in individual tumors of multiple lung cancers is essential for devising an optimal therapeutic strategy. The <i>EGFR</i> mutati...

Full description

Bibliographic Details
Main Authors:	Hyunwoo Lee, Jin Hee Park, Joungho Han, Young Mog Shim, Jhingook Kim, Yong Soo Choi, Hong Kwan Kim, Jong Ho Cho, Yoon-La Choi, Wan-Seop Kim
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Series:	Cancers
Subjects:	lung cancer non-small cell lung carcinoma multiple pulmonary nodules epidermal growth factor receptor
Online Access:	https://www.mdpi.com/2072-6694/14/12/3011

Similar Items

Real-World Analysis of the <i>EGFR</i> Mutation Test in Tissue and Plasma Samples from Non-Small Cell Lung Cancer
by: Hyunwoo Lee, et al.
Published: (2021-09-01)

Adjuvant Chemotherapy in Patients with Node-Negative Non-Small Cell Lung Cancer with Satellite Pulmonary Nodules in the Same Lobe
by: Jiyoun Park, et al.
Published: (2022-02-01)

Deep learning analysis to predict EGFR mutation status in lung adenocarcinoma manifesting as pure ground-glass opacity nodules on CT
by: Hyun Jung Yoon, et al.
Published: (2022-09-01)

Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma
by: Seo Yun Kim, M.D., et al.
Published: (2019-01-01)

Solitary Pulmonary Capillary Hemangioma: CT and PET-CT Features with Clinicopathologic Correlation
by: Min Ju Kim, et al.
Published: (2022-10-01)

Pneumonectomy for Clinical Stage I Non-Small Cell Lung Cancer in Elderly Patients over 70 Years of Age
by: Tae Ho Kim, et al.
Published: (2015-08-01)

Clinicopathological Significance of <i>RUNX1</i> in Non-Small Cell Lung Cancer
by: Yujin Kim, et al.
Published: (2020-06-01)

Favorable Conditions for the Detection of EGFR T790M Mutation Using Plasma Sample in Patients with Non-Small-Cell Lung Cancer
by: Insu Kim, et al.
Published: (2023-02-01)

Differentiating Lung Nodules Due to <i>Coccidioides</i> from Those Due to Lung Cancer Based on Radiographic Appearance
by: Michael W. Peterson, et al.
Published: (2023-06-01)

Feasibility and Safety of a New Chest Drain Wound Closure Method with Knotless Sutures
by: Min Soo Kim, et al.
Published: (2018-08-01)

Surgical Treatment for Non-Small Cell Lung Cancer in Patients on Hemodialysis due to Chronic Kidney Disease: Clinical Outcome and Intermediate-Term Results
by: Byung Jo Park, et al.
Published: (2015-06-01)

Aberrant Methylation of <i>SLIT2</i> Gene in Plasma Cell-Free DNA of Non-Small Cell Lung Cancer Patients
by: Yujin Kim, et al.
Published: (2022-01-01)

Risk Factors for the Development of Nontuberculous Mycobacteria Pulmonary Disease during Long-Term Follow-Up after Lung Cancer Surgery
by: Bo-Guen Kim, et al.
Published: (2022-04-01)

Influence of the Timing of Leptomeningeal Metastasis on the Outcome of <i>EGFR</i>-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable <i>EGFR</i> Mutations in Cerebrospinal Fluid
by: Pei-Ya Liao, et al.
Published: (2022-06-01)

Reappraising the clinical usability of consolidation-to-tumor ratio on CT in clinical stage IA lung cancer
by: Dong Woog Yoon, et al.
Published: (2022-06-01)

Prognostic value of quantitative measurement of EGFR mutation using peptide nucleic acid clamping in advanced EGFR mutant non‐small cell lung cancer patients
by: Insu Kim, et al.
Published: (2019-07-01)

Optimization of Indocyanine Green for Intraoperative Fluorescent Image-Guided Localization of Lung Cancer; Analysis Based on Solid Component of Lung Nodule
by: Ok Hwa Jeon, et al.
Published: (2023-07-01)

Identification of Targetable Liabilities in the Dynamic Metabolic Profile of <i>EGFR</i>-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance
by: Anastasios Gkountakos, et al.
Published: (2022-01-01)

Testing EGFR with Idylla on Cytological Specimens of Lung Cancer: A Review
by: Alessandro Caputo, et al.
Published: (2021-05-01)

Modified Restriction Enzyme-based Detection of EGFR Mutations in Lung Cancer
by: Fan YANG, et al.
Published: (2011-08-01)

Diffuse Lung Metastases in <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer
by: Subba R. Digumarthy, et al.
Published: (2019-09-01)

Proportion and clinical features of never-smokers with non-small cell lung cancer
by: Jaeyoung Cho, et al.
Published: (2017-02-01)

Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases
by: Soomin Ahn, et al.
Published: (2016-07-01)

Landscape of EGFR mutations in lung adenocarcinoma: a single institute experience with comparison of PANAMutyper testing and targeted next-generation sequencing
by: Jeonghyo Lee, et al.
Published: (2022-09-01)

Osimertinib Re-challenge for EGFR-mutant NSCLC after  Osimertinib-induced Interstitial Lung Disease: A Case Report
by: Junjie GU, et al.
Published: (2021-11-01)

Influence of Immunohistochemistry Scoring Criteria in Detecting EGFR Mutations
by: Xin FENG, et al.
Published: (2015-12-01)

Risk factors associated with an increase in the size of ground‐glass lung nodules on chest computed tomography
by: Hee‐Young Yoon, et al.
Published: (2019-07-01)

Development and outcomes of a comprehensive multidisciplinary incidental lung nodule and lung cancer screening program
by: Gregory P. LeMense, et al.
Published: (2020-04-01)

Analysis of Mutations in Epidermal Growth Factor Receptor Gene in Korean Patients with Non-small Cell Lung Cancer: Summary of a Nationwide Survey
by: Sang Hwa Lee, et al.
Published: (2015-11-01)

Correlation Analysis of Ki67 Expression and EGFR Mutation on the Risk of Recurrence and Metastasis in Postoperative Patients with Stage I Lung Adenocarcinoma
by: Lili XU, et al.
Published: (2022-12-01)

How Many Private Data Are Needed for Deep Learning in Lung Nodule Detection on CT Scans? A Retrospective Multicenter Study
by: Jeong Woo Son, et al.
Published: (2022-06-01)

Incidence and Risk Factors of Chronic Pulmonary Aspergillosis Development during Long-Term Follow-Up after Lung Cancer Surgery
by: Sun Hye Shin, et al.
Published: (2020-11-01)

Video-assisted thoracoscopic lobectomy versus open lobectomy in the treatment of large lung cancer: propensity-score matched analysis
by: Jeonghee Yun, et al.
Published: (2022-01-01)

How to Make the Choice in the Retreatment of EGFR-TKI for Advanced NSCLC Patients Who Benefited from Prior Gefitinib Therapy: the Original Drug or Switching to A Second EGFR-TKI?
by: Chuanhao TANG, et al.
Published: (2013-07-01)

Associations of <i>TIMP-3</i> Genetic Polymorphisms with <i>EGFR</i> Statuses and Cancer Clinicopathologic Development in Lung Adenocarcinoma Patients
by: Jer-Hwa Chang, et al.
Published: (2020-10-01)

Potential Impacts of <i>Interleukin-17A</i> Promoter Polymorphisms on the <i>EGFR</i> Mutation Status and Progression of Non-Small Cell Lung Cancer in Taiwan
by: Kai-Ling Lee, et al.
Published: (2021-03-01)

Improvement in Stage of Lung Cancer Diagnosis With Incidental Pulmonary Nodules Followed With a Patient Tracking System and Computerized Registry
by: Laurie L. Carr, MD, et al.
Published: (2022-03-01)

Prevalence and clinical characteristics of malignant lung nodules in tuberculosis endemic area in a single tertiary centre
by: Norsyuhada Zaharudin, et al.
Published: (2022-08-01)

A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLC
by: Gillianne G.Y. Lai, MBBS, et al.
Published: (2022-12-01)

Outcomes of Completion Lobectomy for Locoregional Recurrence after Sublobar Resection in Patients with Non-small Cell Lung Cancer
by: Cho Eun Lee, et al.
Published: (2024-03-01)